MCF Advisors LLC Acquires 43 Shares of Lam Research Co. (NASDAQ:LRCX)

MCF Advisors LLC grew its holdings in Lam Research Co. (NASDAQ:LRCXFree Report) by 860.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 48 shares of the semiconductor company’s stock after acquiring an additional 43 shares during the quarter. MCF Advisors LLC’s holdings in Lam Research were worth $38,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Valued Wealth Advisors LLC acquired a new position in Lam Research in the fourth quarter valued at about $30,000. Orion Capital Management LLC acquired a new position in Lam Research in the third quarter valued at about $25,000. BluePath Capital Management LLC acquired a new position in Lam Research in the third quarter valued at about $28,000. Asset Dedication LLC raised its stake in Lam Research by 56.7% in the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock valued at $30,000 after purchasing an additional 17 shares in the last quarter. Finally, Rakuten Securities Inc. acquired a new position in Lam Research in the fourth quarter valued at about $38,000. Institutional investors own 84.61% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on LRCX. Deutsche Bank Aktiengesellschaft began coverage on Lam Research in a research note on Thursday, April 11th. They issued a “hold” rating and a $1,000.00 price target for the company. UBS Group boosted their target price on Lam Research from $885.00 to $1,130.00 and gave the stock a “buy” rating in a research note on Tuesday, March 5th. The Goldman Sachs Group boosted their target price on Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. TD Cowen boosted their target price on Lam Research from $710.00 to $975.00 and gave the stock an “outperform” rating in a research note on Thursday, January 25th. Finally, Wells Fargo & Company boosted their target price on Lam Research from $930.00 to $980.00 and gave the stock an “equal weight” rating in a research note on Tuesday, April 2nd. Seven research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $931.85.

Read Our Latest Stock Report on Lam Research

Insider Buying and Selling

In other Lam Research news, Director Abhijit Y. Talwalkar sold 882 shares of the firm’s stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $972.03, for a total value of $857,330.46. Following the completion of the sale, the director now owns 10,541 shares of the company’s stock, valued at $10,246,168.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, SVP Seshasayee Varadarajan sold 5,500 shares of the business’s stock in a transaction that occurred on Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the completion of the sale, the senior vice president now owns 22,095 shares in the company, valued at $20,380,648.95. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Abhijit Y. Talwalkar sold 882 shares of the business’s stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $972.03, for a total value of $857,330.46. Following the sale, the director now owns 10,541 shares of the company’s stock, valued at approximately $10,246,168.23. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,029 shares of company stock valued at $6,559,489. 0.32% of the stock is owned by company insiders.

Lam Research Stock Performance

Shares of LRCX stock opened at $868.07 on Tuesday. The business’s 50 day simple moving average is $944.64 and its 200 day simple moving average is $804.00. Lam Research Co. has a one year low of $493.42 and a one year high of $1,007.39. The stock has a market capitalization of $113.80 billion, a PE ratio of 33.57, a PEG ratio of 3.15 and a beta of 1.51. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.06 and a quick ratio of 2.02.

Lam Research (NASDAQ:LRCXGet Free Report) last released its quarterly earnings data on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share for the quarter, beating the consensus estimate of $7.06 by $0.46. The company had revenue of $3.76 billion during the quarter, compared to analyst estimates of $3.71 billion. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. Lam Research’s revenue for the quarter was down 28.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $10.71 EPS. As a group, research analysts forecast that Lam Research Co. will post 28.92 earnings per share for the current year.

Lam Research Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, April 3rd. Stockholders of record on Wednesday, March 13th were paid a $2.00 dividend. The ex-dividend date of this dividend was Tuesday, March 12th. This represents a $8.00 annualized dividend and a dividend yield of 0.92%. Lam Research’s dividend payout ratio is presently 30.94%.

Lam Research Company Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Further Reading

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Co. (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.